Institutional Ownership
Quoin Pharmaceuticals Ltd
CUSIP 74907L409SPONSORED ADSQNRXQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
25.2%
Max % of class reported
Institutional Holders
21
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Adar1 Capital Management, LLC | 13G | 13.0% | 58.2K | SEC |
| 2 | Feb 17, 2026 | Woodline Partners LP | 13G | 9.5% | 2.79M | SEC |
| 3 | Feb 11, 2026 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 2.62M | SEC |
| 4 | Feb 6, 2026 | Ikarian Capital, LLC | 13G/A | 12.6% | 211.5K | SEC |
| 5 | Feb 2, 2026 | Stonepine Capital Management, LLC | 13G/A | 10.6% | — | SEC |
| 6 | Jan 28, 2026 | Aberdeen Group PLC | 13G | 8.9% | 75.0K | SEC |
| 7 | Dec 16, 2025 | Stonepine Capital Management, LLC | 13G | 9.9% | — | SEC |
| 8 | Dec 15, 2025 | Ikarian Capital, LLC | 13G | 25.2% | 211.5K | SEC |
| 9 | Dec 11, 2025 | Resolute Capital Asset Partners LLC | 13G | 8.5% | 50.0K | SEC |
| 10 | Oct 27, 2025 | Integrated Core Strategies (Us) LLC | 13G | 9.0% | 1.90M | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Quoin Pharmaceuticals Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 211.5K | $1.40M |
| 2 | Dauntless Investment Group, LLC | 196.6K | $1.30M |
| 3 | Summittx Capital, L.P. | 100.3K | $662.0K |
| 4 | Velan Capital Investment Management LP | 84.8K | $560.0K |
| 5 | Woodline Partners LP | 79.6K | $525.2K |
| 6 | Millennium Management LLC | 76.2K | $503.2K |
| 7 | Aberdeen Group PLC | 75.0K | $495.0K |
| 8 | Soleus Capital Management, L.P. | 72.7K | $480.0K |
| 9 | Centiva Capital, LP | 60.0K | $396.0K |
| 10 | Boothbay Fund Management, LLC | 59.8K | $394.9K |